Agf Management LTD Apellis Pharmaceuticals, Inc. Transaction History

Agf Management LTD

  • $18.8 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$37.14 - $64.82 $454,147 - $792,618
-12,228 Reduced 17.29%
58,496 $3.5 Million
Q3 2023

Nov 13, 2023
BUY
$23.65 - $89.22 $715,696 - $2.7 Million
30,262 Added 74.79%
70,724 $2.69 Million
Q2 2023

Aug 09, 2023
BUY
$76.68 - $93.31 $3.1 Million - $3.78 Million
40,462 New
40,462 $3.69 Million

Others Institutions Holding APLS

# of Institutions
301
Shares Held
111M
Call Options Held
2.63M
Put Options Held
845K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.67B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Agf Management LTD Portfolio

Follow Agf Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Agf Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email